Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
welke pennystock kan je het beste kopen?
Volgen
Intrasense +91% nu en freeze.
Intrasense freeze omhoog, tweede koopgolf op komst? Laatste koers €0,362 +65%.
Ene freeze is geweest nu de volgende freeze omhoog :-))
Gisteren bij Intrasense een deel rond 41/42 cent verkocht om een groot deel van de mooie stijging om te zetten in effectieve winst. Nu bij de winstnemingen weer bijgekocht met als laatste order een pluk binnen op €0,34. Laatzijde blijft heel dun.
In de slotveiling kocht ik ook nog Intrasense bij op net geen €0,33 :-))
MKB Nedsense heeft een belang in Tib-Tec AG.TIB-TEC AG recently organized an event for its investors on November 29th, 2023 in Amsterdam, hosted by its CEO, Kai Niedermeyer, alongside the Board of Directors. The event served as a platform to provide comprehensive updates on recent achievements, shedding light on significant milestones and outlining the company’s strategic trajectory moving forward. Here are the key highlights from the event: Technology Development Milestones: The event provided an insight on the recent achievements in technology development. TIB-TEC proudly announced the successful results stemming from its latest round of tests, underscoring the company’s commitment to innovation and advancement in its field. Legal and Patent Applications: In addition to technological progress, TIB-TEC also highlighted significant accomplishments in the legal realm, particularly emphasizing progress in patent applications. This underscores the company’s dedication to protecting its intellectual property and fostering a robust foundation for future growth. Industry Focus: An integral component of the event was the discussion surrounding the industries TIB-TEC is targeting. The company provided insights into the specific sectors it aims to penetrate, highlighting strategic opportunities for growth and innovation. Outlook on R&D and Business Development: Attendees were presented a comprehensive outlook on the company’s future endeavors, with a particular focus on Research and Development (R&D) initiatives and Business Development strategies. TIB-TEC delineated the steps ahead, explaining its vision for continued expansion and success. With an impressive turnout of over 80 attendees, the event was a great success. It fostered fruitful interactions and immediate follow-up discussions with investors, who demonstrated their commitment to supporting TIB-TEC’s future growth plans. The enthusiastic engagement of investors underscores the confidence in the company’s vision and potential. In conclusion, the TIB-TEC Investor Event was an important moment in the company’s journey, showcasing notable achievements, outlining strategic priorities, and fostering valuable investor relationships. As TIB-TEC continues to chart a course towards innovation and growth, the event stands as a testament to the company’s firm commitment to excellence and forward-thinking leadership. Zie: tib-tec.com
Intrasense +9,2% al +19% sinds dieptepunt gisteren.
Biosenic op dit moment al 24hr suspended by market operators met een nieuwsbericht op EuroNext over een 'global restructuring plan covering the years 2024-2030'. Voorspelling wat hier de uitkomst van gaat zijn?
StudentBelegger schreef op 12 april 2024 10:46 :
Biosenic op dit moment al 24hr suspended by market operators met een nieuwsbericht op EuroNext over een 'global restructuring plan covering the years 2024-2030'. Voorspelling wat hier de uitkomst van gaat zijn?
Veel nieuwe aandelen en verwatering.
StudentBelegger schreef op 12 april 2024 10:46 :
Biosenic op dit moment al 24hr suspended by market operators met een nieuwsbericht op EuroNext over een 'global restructuring plan covering the years 2024-2030'. Voorspelling wat hier de uitkomst van gaat zijn?
Je kan je geld terugvorderen bij Brugge.
Diede schreef op 12 april 2024 12:31 :
[...]
Je kan je geld terugvorderen bij Brugge.
Vaker stuivers gegraaid bij dit aandeel met kleine bedragen 6-10% pakken op een dag en een paar keer verlies genomen als het orderboek geen stijging meer voorziet. Koers houd zich nog sterk, gezien het orderboek zal de koers nog wel even tussen 0,2 en 0,26 kunnen bungelen. Genoeg ruimte voor daghandel!
Intrasense lichtrood maar laatzijde blijft mager dus ik verwacht verder herstel sinds de dip naar €0,27. Vanochtend bij opening Belysse gekocht op €0,755. Recent waren er nog meerdere insider aankopen tussen 80 en 96 cent.
Diede schreef op 12 april 2024 12:31 :
[...]
Je kan je geld terugvorderen bij Brugge.
Misschien moeten de beleggers die met Lavide de boot in zijn gegaan dat ook maar bij jou doen :-))
BioSenic S.A. • Rue Granbonpré 11 - Building H (box 24) • 1435 Mont-St-Guibert • Belgium (Europe) • Phone: +32 (0)493 09 73 66www.biosenic.com PRESS RELEASE - PRIVILEGED INFORMATION 11/04/2024 1 BioSenic and its restructuring practitioner (Me Yves Brulard) submit a global restructuring plan covering the years 2024-2030 to the Enterprise Court of Nivelles A final circular of the creditors on the basis of XX 83/23 of the Economic Law Code (ELC) will take place before the Court grants authorisation, in accordance with article XX 83/26 of the ELC, to submit the plan to the vote of each class of creditors and to homologation. The creditors will be aware of the plan, which by law contains information that could be privileged. Mont-Saint-Guibert, Belgium, 11 April 2024, 14:00 CET – BioSenic (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy announces that it has finalised a draft plan with the request referred to in Article XX 83/26 ELC with the Enterprise Court of Nivelles. Creditors will be notified to register their claims in RegSol. They will be able to consult this plan in order to then vote on the proposals made. The proposed plan provides for differentiated treatment of creditors by class: • The plan does not affect the recent financing provided through the convertible bond facilities. • Some obligators have been offered to replace their outstanding loans granted to BioSenic for a total principal amount of EUR 7.5 million with new convertible bonds to be issued by BioSenic. The convertible bonds would be unsecured and would have a maturity date of 31 December 2030, which could be further extended by BioSenic for up to 24 months depending on its cash balance. An interest rate of 5% per year, payable annually, with an additional non-compounding interest of 3% per year that would be added to the principal amount upon conversion or repayment of a convertible bond. Under this proposal, which has already been agreed in principle, 200,000 outstanding warrants would be cancelled. The plan, if approved, would remove the conditions precedent previously agreed. • The plan provides that an outstanding EUR 8 million principal loan would be replaced by new convertible bonds to be issued by BioSenic. The convertible bonds would be unsecured and would have a maturity date of 31 December 2030, which could be further extended by BioSenic for up to 24 months depending on its cash balance. An interest rate of 5% per year, payable annually, with an additional non-compounding interest of 3% per year that will be added to the principal amount upon conversion or repayment of a convertible bond. If the plan is approved, 800,000 outstanding warrants would also be cancelled. • With regard to the ordinary creditors, the plan provides for a payment by BioSenic of 5% of the claim on the last day of the 5th year of the plan. • With respect to the lessor, the plan provides for the extraordinary part 100% immediately and the balance in ordinary. • Regarding the strategic creditors, the plan provides for 90% over 5 years depending on cash inflows and no later than the last day of the 5th year of the plan. • For the accessories employee, the plan provides for 99% immediately. • The plan provides, for the very useful creditors, for 50% within 2 years. • Regarding the InterCos debts, the plan provides for 5% immediately. • Finally, with regard to the shareholders, the plan provides for the allocation of subscription rights, the terms of which will be determined at a later date by BioSenic. The plan includes a participation clause at the reorganisation value, due on the last day of the 5th year following the homologation of the plan on the basis of the average share price over the preceding 90 days. This participation amount – to be deducted from the company's own financing capacity for projects in the 5th year, with trials to be started or even maintained on new indications – will be due on the last day of the 5th year following the homologation of the plan, and will be assessed on the basis of the average share price over the preceding 90 days: the average share price will have to reach the level observed for the shares of BioSenic in 2017 while a Phase III was ongoing (JTA004). At that time, the share price stood at EUR 10. If this level is reached, the participation of every creditor will be increased by 10% of the debt written off.
Belysse inmiddels al +7,3% sinds opening. Biosenic ook in de plus :-))
Belysse +10% sinds opening, nu freeze omhoog.
Er zal waarschijnlijk iets spelen bij Intrasense, dat gaat een knalopening worden naar boven van bijna +25%.
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
882,27
-0,04%
EUR/USD
1,0727
+0,29%
FTSE 100
8.147,03
+0,09%
Germany40^
18.118,40
-0,23%
Gold spot
2.345,62
+0,33%
NY-Nasdaq Composite
15.927,90
+2,03%
Stijgers
Dalers